论文标题
基于细胞囊泡的药物输送的端到端分子通信模型
The End-to-End Molecular Communication Model of Extracellular Vesicle-based Drug Delivery
论文作者
论文摘要
仔细观察自然已经引起了人们对探索和利用由细胞作为内在的,完美的生物相容性基础设施组成的体体内通信网络的兴趣。正在操纵天然存在的细胞对细胞通信系统以释放,导航和接收可溶性细胞衍生的使者,这些使者本质上是治疗性的,或者在其结构中携带治疗性分子货物。这种结构的一个例子是细胞外囊泡(EV),最近已被证明具有有利的药代动力学特性,为开发下一代生物治疗剂开辟了新的途径。在本文中,我们通过利用信息和通信技术样方法来分析分子通信系统,研究心脏组织内EV转移的理论方面。我们的建模意味着EV释放细胞作为发射机的抽象,细胞外基质作为通道,而EV接收细胞作为接收器。我们的结果是从开发的分析模型得出的,表明可以使用电信号等外力调制释放,并且可以分别受细胞外基质和质膜特性的转移和接收。结果可以预测EV生物分布,并有助于避免计划外的给药,通常会导致侧面和不利影响。
A closer look at nature has recently brought more interest in exploring and utilizing intra-body communication networks composed of cells as intrinsic, perfectly biocompatible infrastructures to deliver therapeutics. Naturally occurring cell-to-cell communication systems are being manipulated to release, navigate, and take up soluble cell-derived messengers that are either therapeutic by nature or carry therapeutic molecular cargo in their structures. One example of such structures is extracellular vesicles (EVs) which have been recently proven to have favorable pharmacokinetic properties, opening new avenues for developing the next generation biotherapeutics. In this paper, we study theoretical aspects of the EV transfer within heart tissue as a case study by utilizing an information and communication technology-like approach in analyzing molecular communication systems. Our modeling implies the abstraction of the EV releasing cells as transmitters, the extracellular matrix as the channel, and the EV receiving cells as receivers. Our results, derived from the developed analytical models, indicate that the release can be modulated using external forces such as electrical signals, and the transfer and reception can be affected by the extracellular matrix and plasma membrane properties, respectively. The results can predict the EV biodistributions and contribute to avoiding unplanned administration, often resulting in side- and adverse effects.